Adamas pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Adamas pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 24.218 million compared to usd 28.687 million a year ago. net loss was usd 27.582 million compared to usd 33.152 million a year ago. basic loss per share was usd 0.99 compared to usd 1.22 a year ago. for the nine months, operating loss was usd 72.676 million compared to usd 89.723 million a year ago. net loss was usd 82.111 million compared to usd 102.116 million a year ago. basic loss per share was usd 2.97 compared to usd 3.82 a year ago.
ADMS Ratings Summary
ADMS Quant Ranking